GLP-1 receptor agonist protects glucose-stimulated insulin secretion in pancreatic β-cells against lipotoxicity via PPARδ/UCP2 pathway.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- GLP-1 receptor agonist protects glucose-stimulated insulin secretion in pancreatic β-cells against lipotoxicity via PPARδ/UCP2 pathway.
- Published In:
- Cellular and molecular life sciences : CMLS, 82(1), 375 (2025)
- Authors:
- Liu, Zhigu, Chen, Yalan, Su, Yanna, Peng, Yueyue, Xu, Fen, Yao, Bin, Liang, Hua, Lin, Beisi, Xu, Wen
- Database ID:
- RPEP-12271
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12271APA
Liu, Zhigu; Chen, Yalan; Su, Yanna; Peng, Yueyue; Xu, Fen; Yao, Bin; Liang, Hua; Lin, Beisi; Xu, Wen. (2025). GLP-1 receptor agonist protects glucose-stimulated insulin secretion in pancreatic β-cells against lipotoxicity via PPARδ/UCP2 pathway.. Cellular and molecular life sciences : CMLS, 82(1), 375. https://doi.org/10.1007/s00018-025-05844-0
MLA
Liu, Zhigu, et al. "GLP-1 receptor agonist protects glucose-stimulated insulin secretion in pancreatic β-cells against lipotoxicity via PPARδ/UCP2 pathway.." Cellular and molecular life sciences : CMLS, 2025. https://doi.org/10.1007/s00018-025-05844-0
RethinkPeptides
RethinkPeptides Research Database. "GLP-1 receptor agonist protects glucose-stimulated insulin s..." RPEP-12271. Retrieved from https://rethinkpeptides.com/research/liu-2025-glp1-receptor-agonist-protects
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.